Park Place Capital Corp Atri Cure, Inc. Transaction History

Park Place Capital Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 02, 2024	SELL	$19.86 - $29.09 $1,688 - $2,472	-85 Reduced 73.28%	31 $0
Q1 2024 Apr 18, 2024	BUY	$28.21 - $37.78 $874 - $1,171	31 Added 36.47%	116 $3,000
Q4 2023 Jan 24, 2024	SELL	$32.99 - $43.25 $14,680 - $19,246	-445 Reduced 83.96%	85 $3,000
Q1 2023 May 02, 2023	BUY	$35.87 - $47.22 $4,412 - $5,808	123 Added 30.22%	530 $21,000
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $13,626 - $19,312	407 New	407 $18,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Park Place Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Park Place Capital Corp with notifications on news.